Bay 59-3074
Bay 59-3074 is a selective cannabinoid CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors, respectively. Bay 59-3074 has analgesic properties[1].
Product Specifications
CAS Number
[406205-74-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H320, H335
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Bay-59-3074.html
Purity
98.60
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=S(CCCC(F)(F)F)(OC1=CC=CC(OC2=CC=CC(C(F)(F)F)=C2C#N)=C1)=O
Molecular Formula
C18H13F6NO4S
Molecular Weight
453.36
Precautions
H302, H315, H320, H335
References & Citations
[1]De Vry J et al. 3-[2-cyano-3- (trifluoromethyl) phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074) : a novelcannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects. J Pharmacol Exp Ther. 2004 Aug;310 (2) :620-32.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB1; CB2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS642680-01 0.1 mg
COG2 (LDLC, Conserved Oligomeric Golgi Complex Subunit 2, Component of Oligomeric Golgi Complex 2, Low Density Lipoprotein Receptor Defect C-complementing Protein)
Ask
View Details 
MBS642680-02 5x 0.1 mg
COG2 (LDLC, Conserved Oligomeric Golgi Complex Subunit 2, Component of Oligomeric Golgi Complex 2, Low Density Lipoprotein Receptor Defect C-complementing Protein)
Ask
View Details 